A detailed history of 180 Wealth Advisors, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 132,549 shares of HQL stock, worth $1.77 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
132,549
Previous 122,995 7.77%
Holding current value
$1.77 Million
Previous $1.66 Million 9.12%
% of portfolio
0.33%
Previous 0.33%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$13.38 - $14.33 $127,832 - $136,908
9,554 Added 7.77%
132,549 $1.81 Million
Q4 2023

Jan 24, 2024

BUY
$11.35 - $13.6 $93,875 - $112,485
8,271 Added 7.21%
122,995 $1.66 Million
Q3 2023

Oct 31, 2023

BUY
$12.38 - $13.69 $70,875 - $78,375
5,725 Added 5.25%
114,724 $1.43 Million
Q2 2023

Jul 11, 2023

SELL
$13.13 - $14.17 $37,512 - $40,483
-2,857 Reduced 2.55%
108,999 $1.48 Million
Q1 2023

Apr 07, 2023

BUY
$13.37 - $14.94 $32,061 - $35,826
2,398 Added 2.19%
111,856 $1.56 Million
Q4 2022

Feb 02, 2023

BUY
$13.55 - $15.23 $83,007 - $93,298
6,126 Added 5.93%
109,458 $1.56 Million
Q3 2022

Oct 12, 2022

BUY
$13.39 - $16.31 $111,685 - $136,041
8,341 Added 8.78%
103,332 $1.41 Million
Q2 2022

Jul 11, 2022

BUY
$13.11 - $17.02 $129,880 - $168,617
9,907 Added 11.64%
94,991 $1.38 Million
Q1 2022

Apr 22, 2022

BUY
$15.35 - $19.29 $254,103 - $319,326
16,554 Added 24.16%
85,084 $1.43 Million
Q4 2021

Jan 26, 2022

BUY
$18.5 - $21.59 $100,418 - $117,190
5,428 Added 8.6%
68,530 $1.19 Million
Q3 2021

Oct 28, 2021

SELL
$20.27 - $22.67 $9,526 - $10,654
-470 Reduced 0.74%
63,102 $1.3 Million
Q2 2021

Aug 13, 2021

SELL
$19.14 - $21.44 $3,694 - $4,137
-193 Reduced 0.3%
63,572 $1.38 Million
Q1 2021

May 25, 2021

BUY
$19.31 - $22.07 $122,792 - $140,343
6,359 Added 11.08%
63,765 $1.26 Million
Q4 2020

Jan 27, 2021

BUY
$16.8 - $20.21 $4,720 - $5,679
281 Added 0.49%
57,406 $1.19 Million
Q3 2020

Oct 23, 2020

SELL
$16.71 - $19.06 $15,757 - $17,973
-943 Reduced 1.62%
57,125 $1.01 Million
Q2 2020

Jul 21, 2020

SELL
$14.22 - $18.38 $83,044 - $107,339
-5,840 Reduced 9.14%
58,068 $1.1 Million
Q1 2020

Apr 09, 2020

BUY
$12.22 - $17.99 $59,755 - $87,971
4,890 Added 8.29%
63,908 $938,000
Q4 2019

Jan 17, 2020

BUY
$14.63 - $17.84 $109,827 - $133,924
7,507 Added 14.57%
59,018 $1.05 Million
Q3 2019

Oct 22, 2019

BUY
$15.09 - $17.09 $164,797 - $186,639
10,921 Added 26.91%
51,511 $766,000
Q2 2019

Aug 05, 2019

BUY
$15.54 - $17.47 $80,497 - $90,494
5,180 Added 14.63%
40,590 $664,000
Q1 2019

May 14, 2019

BUY
$15.5 - $17.9 $548,855 - $633,839
35,410 New
35,410 $581,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track 180 Wealth Advisors, LLC Portfolio

Follow 180 Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.